AP Biosciences advances next-generation bispecific antibody therapies for solid tumor immunotherapy

2025-09-22 / GlobalBio & Investment

APBiosciences,Inc.isadvancingnext-generationCD137bispecificantibodytherapiesforsolidtumorimmunotherapy. AttheTaiwanImmuno-OncologyDrugDevelopmentForum,founderDr.JengHersharedhowAPBiosciencesisdifferen...

GBIHighlights Oncology mRNA Immunotherapy

Elixiron Targets T-Cell Exhaustion with Next-Gen Cancer Immunotherapies

2025-09-18 / GlobalBio & Investment

On16thSeptember,Dr.Hung-KaiChen,Founder&CEOofElixironImmunotherapeutics,sharedthecompany’sinnovativepipelineaddressingoneofthetoughestchallengesinoncology—TcellexhaustionattheTaiwanImm...

GBIHighlights ICI Immunotherapy Oncology

GNT Biotech Advances GNTbm-38 with IND Filings in US & China by 2026

2025-09-18 / GlobalBio & Investment

GNTBiotech&MedicalsCorporation(GNTbm)isadvancingGNTbm-38,anext-generationoralimmuno-regulatorydrug,withINDfilingsplannedintheUS&Chinabyearly2026.InvestmentHighlightsGlobalIPStrength:38inventio...

GBIHighlights CancerTherapy Immunotherapy

Taking on 5 Cancers? This Biotech Aims for 2025 IPO!

2025-03-08 / GlobalBio & Investment

HanchorBio,ledbyChairmanDr.ScottLiu,isbreakingbarriersintumorimmunotherapy!WithitsB-roundfundingsecuredin2024,thecompanyissettoadvanceHCB101intoPhase1b/2aclinicaltrialsinQ12025,targetingfivetypesofcan...

GBIHighlights ProtectBio PetHealth AnimalCancer Immunotherapy

Protect Companion Pet's Healthcare

2025-02-17 / GlobalBio & Investment

Didyouknowthatpets,likehumans,cangetcancer?Thisbiotechcompany,ProtectBiotech (alsoknownasProtectAnimalHealthInc),isdevelopingcancerimmunotherapyforanimals,includingabroad-spectrumPD-L1/CTLA-4vaccinefo...